TMC125-C223: TMC125 in HIV-1 Infected Subjects

NCT00081978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: TMC125

Sponsor

Tibotec Pharmaceuticals, Ireland